Higher polygenetic risk scores for schizophrenia, depression, neuroticism, and alcohol use disorder are indicators for higher risk of nicotine dependence.
People with a history of substance use disorder are more susceptible to COVID-19 infection and have an increased risk of experiencing worse outcomes, a new study reports.
People with mood and substance use disorders have reduced lifespan compared to their peers without a mental health disorder. Those with mood disorders have an increased death risk as a result of health conditions such as cancer, cardiovascular disease, and diabetes. Men with mood disorders experience a reduced life expectancy of 7.9 years, and women 6.2 years, compared to those with no history of depression or anxiety.
An intervention treatment called Mindful Awareness in Body-oriented Therapy, or MABT, helps women recover from, and prevents relapse, in substance use disorder when used in conjunction with community-based programs.